The increase in MERTK could reflect upregulation of the protein in response to chemotherapy treatment to promote tumor cell survival or selective survival of cells expressing higher levels of MERTK protein, providing rationale for MERTK inhibition in combination with cytotoxic chemotherapy for treatment of GBM. The gene discussed is MERTK; the disease is neoplasm.